Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth. - Wikidata - awgldk - TriplyDB

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

http://www.wikidata.org/entity/Q37144044

about

Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma.Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer.High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-induced NF-κB activation and predicts poor prognosis in human glioma.Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway.Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies.Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.

P2860

Q33909648-E2E6CA46-CF72-47C1-90F2-6B519884D9F5 Q38613413-AA8017CD-5375-4014-9B28-2FCBF34844BD Q42363894-BDA5208A-A7ED-41EE-BAFE-8E1C68479749 Q47109965-E504F711-F9EB-4667-B6AD-6B73F8F3A762 Q47379071-AAA29355-32D8-404B-A8B7-54ABFCBFD5D6 Q47875518-42890E31-A059-4B07-ADE5-870F065DD798 Q52645038-6F20844B-655D-4DBF-8DC2-CB126377CEB4 Q54114538-B61E912B-FFF4-4415-AD93-7BF82A749639

P2860

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

http://www.wikidata.org/entity/Q37144044

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@en

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@nl

type

label

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@en

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@nl

prefLabel

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@en

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@nl

P1433

Q37144044-34BC26F9-D9F2-470C-B2A2-8F069E1101F7

P1476

Q37144044-BB156879-9501-48AA-B88B-922946F07630

P2093

Q37144044-0255AF49-3223-470E-BE45-9F2DBC33BE75

Q37144044-3F850CDE-CD1D-443E-8D8B-D275B00C12DD

Q37144044-40E0AC05-498E-4A07-A7F5-49A16DE5A116

Q37144044-F385D392-1FAF-48C6-BF24-2FCDEDA065EC

P2860

Q37144044-0DE25BEA-55C5-4D14-9C29-D9495F1EE8B6

Q37144044-4618FF55-7A36-4D8E-8D83-045DD00DA5B6

Q37144044-5DF38C2F-253A-45ED-AA4D-6B5AFDFCE1FF

Q37144044-67D0917C-0FD1-4F40-A151-A9FF3ECD6601

Q37144044-7650D705-34DD-4AD8-88F2-25A18B74A02A

Q37144044-959861D9-AB9A-4898-8F42-75DA12E4F1F6

Q37144044-9BE4F49C-2535-4DF0-8C65-AE790273D6F1

Q37144044-AEFFB252-ECF1-417A-9573-7C72B194C8F8

Q37144044-B29CB5B1-184B-4461-9B2D-C5AB0C02CD08

Q37144044-C2C0F7E1-47E3-45B7-B0D4-43A461949B43

P304

Q37144044-BD4B31C0-EA7D-46CB-8B05-4B3608AE18B5

P31

Q37144044-383E9CAA-4707-4F9A-8618-62A2EDCBEE05

P407

Q37144044-155EC45C-FE22-4D72-BEC2-1976ECFCD7DC

P433

Q37144044-C06860A0-45DF-401B-89E7-30B5992DA22F

P478

Q37144044-44984445-A831-4141-A9A1-03DB29B7B5C0

P577

Q37144044-C2EEE0FC-716D-49DF-A99F-ED867935AB75

P698

Q37144044-09D10E7E-8634-4CEB-BA52-50D4329CFEF2

P932

Q37144044-BC1F43C0-5FE6-48AC-BBC3-33977768D9B7

P1433

American Journal of Translational Research

P1476

Targeting Btk with ibrutinib inhibit gastric carcinoma cells growth.

@en

P2093

Feng Tao

http://www.w3.org/2001/XMLSchema#string

Jin Dao Wang

http://www.w3.org/2001/XMLSchema#string

Ke Wei Ji

http://www.w3.org/2001/XMLSchema#string

Xiao Ying Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Metadherin contribute to BCR signaling in chronic lymphocytic leukemia

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo.

Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells.

Bruton's tyrosine kinase (Btk) inhibitor ibrutinib suppresses stem-like traits in ovarian cancer.

Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.

Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemia.

Irreversible dual inhibitory mode: the novel Btk inhibitor PLS-123 demonstrates promising anti-tumor activity in human B-cell lymphoma.

Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo.

Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo

Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis

P304

3003-3012

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27508020

http://www.w3.org/2001/XMLSchema#string

P932

4969436

http://www.w3.org/2001/XMLSchema#string